Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depressive Disorder, Treatment-resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00220480
What this trial is testing

A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression

Who this might be right for
Depressive Disorder, Major
Sheba Medical Center 60
Not applicableUnknownNCT06350396
What this trial is testing

PBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive Disorder
Changping Laboratory 270
Testing effectiveness (Phase 2)Looking for participantsNCT06511908
What this trial is testing

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Who this might be right for
SuicideDepressive Disorder, Treatment-ResistantKetamine+10 more
National Institute of Mental Health (NIMH) 50
Not applicableStudy completedNCT03191058
What this trial is testing

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression

Who this might be right for
DepressionUnipolar DepressionTreatment Resistant Depression
University of Texas Southwestern Medical Center 239
Not applicableUnknownNCT05716555
What this trial is testing

Deep Brain Stimulation for Treatment Resistant Depression

Who this might be right for
Depressive Disorder, Major
Second Affiliated Hospital, Zhejiang University, School of Medicine 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT06341426
What this trial is testing

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

Who this might be right for
Major Depressive DisorderDepressionTreatment-Resistant Depression+1 more
University Health Network, Toronto 92
Testing effectiveness (Phase 2)Study completedNCT01882829
What this trial is testing

Nuedexta in Treatment-Resistant Major Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant
James Murrough 20
Not applicableStudy completedNCT06615804
What this trial is testing

The Effects of Transcranial Magnetic Stimulation on Retina and Choroidal Structures

Who this might be right for
Major Depressive Disorders
Gulhane Training and Research Hospital 58
Not applicableStudy completedNCT02429011
What this trial is testing

MRI Studies of Emotion in Depression

Who this might be right for
Major Depressive Disorder
Icahn School of Medicine at Mount Sinai 135
Not applicableStudy completedNCT07077291
What this trial is testing

MBCT and Escitalopram for Treatment-Resistant Depression in Older Adults

Who this might be right for
Treatment-resistant Depression (TRD)
Yun Zhang 230
Early research (Phase 1)Study completedNCT06138691
What this trial is testing

KET-RO Plus RO DBT for Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
Washington University School of Medicine 16
Testing effectiveness (Phase 2)Study completedNCT05339074
What this trial is testing

Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Disorder+1 more
Joshua Rosenblat 41
Post-approval studies (Phase 4)Study completedNCT04599855
What this trial is testing

Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

Who this might be right for
Depressive Disorder, Treatment-Resistant
Janssen Research & Development, LLC 477
Early research (Phase 1)Ended earlyNCT02942368
What this trial is testing

Adaptive tDCS for Treatment-Resistant MDD

Who this might be right for
Depressive Disorder, Treatment-Resistant
Washington University School of Medicine 5
Not applicableLooking for participantsNCT07127913
What this trial is testing

Closed-Loop Deep Brain Stimulation for Treatment-Resistant Bipolar Depression

Who this might be right for
Bipolar II DisorderBipolar II Disorder, Most Recent Episode Major Depressive
Andrew Krystal 10
Not applicableWithdrawnNCT01613820
What this trial is testing

Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Massachusetts General Hospital
Not applicableLooking for participantsNCT04996433
What this trial is testing

A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatients

Who this might be right for
Persistent Depressive DisorderTreatment-resistant Depression
University of Greifswald 396
Post-approval studies (Phase 4)Looking for participantsNCT06748209
What this trial is testing

Establishing Mobile Transcranial Magnetic Stimulation

Who this might be right for
Treatment Resistant Major Depression
Medical University of South Carolina 30
Post-approval studies (Phase 4)Ended earlyNCT00296686
What this trial is testing

Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression

Who this might be right for
Major Depression
New York State Psychiatric Institute 31
Early research (Phase 1)Looking for participantsNCT03973268
What this trial is testing

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

Who this might be right for
DepressionMajor Depressive DisorderMajor Depression
National Institute of Mental Health (NIMH) 70
Next Page